RXDX

Prometheus Biosciences, Inc.CIK 1718852 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for RXDX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for RXDX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Hendrix Martin	Director	6	$0	$0	2023-06-16
Laur James	Director	6	$0	$0	2023-06-16
McKenna Mark C.	Chairman, President and CEO	40	$0	$14.99M	2023-06-16
Stenhouse Mark	Chief Operating Officer	14	$266.0K	$0	2023-06-16
Marshall Keith W	Chief Financial Officer	27	$0	$3.50M	2023-06-16
Adams Helen C.	Director	8	$9.5K	$0	2023-06-16
Swain Judith L	Director	5	$0	$0	2023-06-16
Szela Mary T	Director	6	$0	$0	2023-06-16
PAPA JOSEPH C	Director	13	$285.0K	$0	2023-06-16
Hassan Fred	Director	8	$0	$0	2023-06-16
Cedars Sinai Intellectual Property Co	10% Owner	2	$0	$99.12M	2023-03-08
Luo Allison	Chief Medical Officer	2	$0	$0	2021-11-14
Andrews Timothy K.	General Counsel	1	$0	$0	2021-11-14
Point72 Biotech Private Investments, LLC	Other	5	$15.20M	$0	2021-03-16
Cormorant Global Healthcare Master Fund, LP	Other	4	$7.13M	$0	2021-03-16
WONG RODERICK	10% Owner	5	$15.20M	$0	2021-03-16
Yamada Tadataka	Director	2	$0	$0	2021-03-16
CEDARS SINAI MEDICAL CENTER	10% Owner	10	$0	$0	2021-03-16
PERCEPTIVE ADVISORS LLC	10% Owner	5	$16.15M	$0	2021-03-16
McCarthy William R	Chief Business Officer	7	$0	$0	2018-02-08
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Controls	8	$0	$0	2018-02-08
Chacko Jacob	Chief Financial Officer	18	$117.2K	$0	2018-02-08
Hornby Zachary	Chief Operating Officer	21	$0	$0	2018-02-08
Bristol James A	Director	8	$28.3K	$0	2018-02-08
Multani Pratik S	Chief Medical Officer	9	$0	$0	2018-02-08
Hoerter Steven L.	Director	4	$0	$0	2018-02-08
Casdin Alexander W.	Director	14	$6.69M	$0	2018-02-08
Kuhlen Christian V	General Counsel and Secretary	7	$0	$0	2018-02-08
Dreismann Heiner	Director	9	$0	$0	2018-02-08
Freddo James L	Director	10	$16.2K	$0	2018-02-08
Lim Jonathan E	President, CEO and Director	22	$464.5K	$0	2018-02-08
City Hill Venture Partners I, LLC	10% Owner	5	$246.3K	$0	2016-03-17
WILD ROBERT	Sr. VP, Research and CSO	4	$19.6K	$0	2016-01-07
BILINSKY IGOR	GM, Immuno-Oncology/SVP Sp Ops	2	$0	$0	2016-01-07
Onaitis Matthew	General Counsel and Secretary	3	$0	$0	2016-01-07
Parker Bernard	Chief Commercial Officer	1	$0	$0	2015-07-22
Senderowicz Adrian	Chief Medical Officer	2	$0	$0	2015-01-08

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Adams Helen C.	Director	D To issuer deriv	2023-06-16	2023-06-16	30,000	—	$0	0	SEC↗
Adams Helen C.	Director	D To issuer deriv	2023-06-16	2023-06-16	1,083	—	$0	0	SEC↗
Adams Helen C.	Director	D To issuer deriv	2023-06-16	2023-06-16	21,526	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	52,838	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	93,040	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	135,913	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	102,155	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	86,582	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	12,920	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer deriv	2023-06-16	2023-06-16	34,085	—	$0	0	SEC↗
Szela Mary T	Director	D To issuer deriv	2023-06-16	2023-06-16	40,000	—	$0	0	SEC↗
Szela Mary T	Director	D To issuer deriv	2023-06-16	2023-06-16	20,500	—	$0	0	SEC↗
Swain Judith L	Director	D To issuer deriv	2023-06-16	2023-06-16	20,500	—	$0	0	SEC↗
Swain Judith L	Director	D To issuer deriv	2023-06-16	2023-06-16	30,000	—	$0	0	SEC↗
Laur James	Director	D To issuer deriv	2023-06-16	2023-06-16	20,500	—	$0	0	SEC↗
Laur James	Director	D To issuer deriv	2023-06-16	2023-06-16	40,000	—	$0	0	SEC↗
Hassan Fred	Director	D To issuer deriv	2023-06-16	2023-06-16	541	—	$0	0	SEC↗
Hassan Fred	Director	D To issuer deriv	2023-06-16	2023-06-16	40,000	—	$0	0	SEC↗
Hassan Fred	Director	D To issuer deriv	2023-06-16	2023-06-16	21,013	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer deriv	2023-06-16	2023-06-16	27,340	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer deriv	2023-06-16	2023-06-16	15,000	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer deriv	2023-06-16	2023-06-16	22,652	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer deriv	2023-06-16	2023-06-16	2,165	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer deriv	2023-06-16	2023-06-16	22,551	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	246,639	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	290,000	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	132,741	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	128,930	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	161,105	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	20,000	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	481,725	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer deriv	2023-06-16	2023-06-16	566,307	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer deriv	2023-06-16	2023-06-16	86,582	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer deriv	2023-06-16	2023-06-16	34,085	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer deriv	2023-06-16	2023-06-16	70,371	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer deriv	2023-06-16	2023-06-16	240,000	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer deriv	2023-06-16	2023-06-16	40,000	—	$0	0	SEC↗
Hendrix Martin	Director	D To issuer deriv	2023-06-16	2023-06-16	40,000	—	$0	0	SEC↗
Hendrix Martin	Director	D To issuer deriv	2023-06-16	2023-06-16	20,500	—	$0	0	SEC↗
Adams Helen C.	Director	D To issuer	2023-06-16	2023-06-16	2,674	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	D To issuer	2023-06-16	2023-06-16	87,973	—	$0	0	SEC↗
Szela Mary T	Director	D To issuer	2023-06-16	2023-06-16	2,071	—	$0	0	SEC↗
Swain Judith L	Director	D To issuer	2023-06-16	2023-06-16	2,071	—	$0	0	SEC↗
Laur James	Director	D To issuer	2023-06-16	2023-06-16	2,071	—	$0	0	SEC↗
Hassan Fred	Director	D To issuer	2023-06-16	2023-06-16	2,123	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer	2023-06-16	2023-06-16	10,000	—	$0	0	SEC↗
PAPA JOSEPH C	Director	D To issuer	2023-06-16	2023-06-16	7,278	—	$0	0	SEC↗
McKenna Mark C.	Chairman, President and CEO	D To issuer	2023-06-16	2023-06-16	178,098	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer	2023-06-16	2023-06-16	12,754	—	$0	0	SEC↗
Stenhouse Mark	Chief Operating Officer	D To issuer	2023-06-16	2023-06-16	14,000	—	$0	0	SEC↗
Hendrix Martin	Director	D To issuer	2023-06-16	2023-06-16	2,071	—	$0	0	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise deriv	2023-06-02	2023-06-02	78,162	—	$0	52,838	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-06-02	2023-06-02	3	—	$0	132,741	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-06-02	2023-06-02	122,528	—	$0	161,105	SEC↗
PAPA JOSEPH C	Director	J Other	2023-06-02	2023-06-02	10,000	—	$0	7,278	SEC↗
PAPA JOSEPH C	Director	J Other	2023-06-02	2023-06-02	10,000	—	$0	10,000	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise	2023-06-02	2023-06-02	78,162	$3.10	$242.3K	87,973	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-06-02	2023-06-02	122,528	$2.90	$355.3K	177,672	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-06-02	2023-06-02	3	$1.70	$5	178,036	SEC↗
Stenhouse Mark	Chief Operating Officer	J Other	2023-06-01	2023-06-02	14,000	—	$0	12,708	SEC↗
Stenhouse Mark	Chief Operating Officer	J Other	2023-06-01	2023-06-02	14,000	—	$0	14,000	SEC↗
Adams Helen C.	Director	A Award	2023-05-19	2023-05-19	2,174	—	$0	2,674	SEC↗
Hassan Fred	Director	A Award	2023-05-19	2023-05-19	2,123	—	$0	2,123	SEC↗
Hendrix Martin	Director	A Award	2023-05-19	2023-05-19	2,071	—	$0	2,071	SEC↗
Laur James	Director	A Award	2023-05-19	2023-05-19	2,071	—	$0	2,071	SEC↗
PAPA JOSEPH C	Director	A Award	2023-05-19	2023-05-19	2,278	—	$0	17,278	SEC↗
Swain Judith L	Director	A Award	2023-05-19	2023-05-19	2,071	—	$0	2,071	SEC↗
Szela Mary T	Director	A Award	2023-05-19	2023-05-19	2,071	—	$0	2,071	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise deriv	2023-04-05	2023-04-07	10,000	—	$0	93,040	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise	2023-04-05	2023-04-07	10,000	$3.70	$37.0K	19,811	SEC↗
Marshall Keith W	Chief Financial Officer	S Sale	2023-04-05	2023-04-07	10,000	$108.42	$1.08M	9,811	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-03-15	2023-03-17	25,000	—	$0	283,633	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-03-15	2023-03-17	25,000	$2.90	$72.5K	80,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-03-15	2023-03-17	25,000	$116.14	$2.90M	55,144	SEC↗
Cedars Sinai Intellectual Prop	10% Owner	S Sale	2023-03-08	2023-03-08	865,000	$114.59	$99.12M	4,001,132	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise deriv	2023-03-06	2023-03-08	10,000	—	$0	103,040	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise	2023-03-06	2023-03-08	10,000	$3.70	$37.0K	19,811	SEC↗
Marshall Keith W	Chief Financial Officer	S Sale	2023-03-06	2023-03-08	10,000	$122.13	$1.22M	9,811	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-03-03	2023-03-03	10,620	—	$0	481,725	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-03-03	2023-03-03	10,620	$3.70	$39.3K	65,764	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-03-03	2023-03-03	10,620	$125.13	$1.33M	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-03-01	2023-03-03	700	—	$0	492,345	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-03-01	2023-03-03	700	$3.70	$2.6K	55,844	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-03-01	2023-03-03	700	$125.26	$87.7K	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-02-17	2023-02-17	13,680	—	$0	493,045	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-02-17	2023-02-17	13,680	$125.10	$1.71M	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-02-17	2023-02-17	13,680	$3.70	$50.6K	68,824	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-02-16	2023-02-17	25,000	—	$0	506,725	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-02-16	2023-02-17	25,000	$3.70	$92.5K	80,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-02-16	2023-02-17	25,000	$119.87	$3.00M	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-02-15	2023-02-17	25,000	—	$0	308,633	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise deriv	2023-02-15	2023-02-17	5,000	—	$0	113,040	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-02-15	2023-02-17	25,000	$119.42	$2.99M	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-02-15	2023-02-17	25,000	$2.90	$72.5K	80,144	SEC↗
Marshall Keith W	Chief Financial Officer	S Sale	2023-02-15	2023-02-17	5,000	$119.38	$596.9K	9,811	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise	2023-02-15	2023-02-17	5,000	$3.70	$18.5K	14,811	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2023-01-17	2023-01-19	25,000	—	$0	333,633	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise deriv	2023-01-17	2023-01-19	5,000	—	$0	118,040	SEC↗
McKenna Mark C.	Chairman, President & CEO	S Sale	2023-01-17	2023-01-19	25,000	$118.99	$2.97M	55,144	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2023-01-17	2023-01-19	25,000	$2.90	$72.5K	80,144	SEC↗
Marshall Keith W	Chief Financial Officer	S Sale	2023-01-17	2023-01-19	5,000	$119.00	$595.0K	9,811	SEC↗
Marshall Keith W	Chief Financial Officer	M Exercise	2023-01-17	2023-01-19	5,000	$3.70	$18.5K	14,811	SEC↗
Marshall Keith W	Chief Financial Officer	A Award deriv	2022-12-16	2022-12-20	12,920	—	$0	12,920	SEC↗
McKenna Mark C.	Chairman, President & CEO	A Award deriv	2022-12-09	2022-12-13	128,930	—	$0	128,930	SEC↗
Marshall Keith W	Chief Financial Officer	A Award deriv	2022-12-09	2022-12-13	34,085	—	$0	34,085	SEC↗
Stenhouse Mark	Chief Operating Officer	A Award deriv	2022-12-09	2022-12-13	34,085	—	$0	34,085	SEC↗
McKenna Mark C.	Chairman, President & CEO	A Award	2022-12-09	2022-12-13	37,113	—	$0	55,144	SEC↗
Marshall Keith W	Chief Financial Officer	A Award	2022-12-09	2022-12-13	9,811	—	$0	9,811	SEC↗
Stenhouse Mark	Chief Operating Officer	A Award	2022-12-09	2022-12-13	9,811	—	$0	26,442	SEC↗
McKenna Mark C.	Chairman, President & CEO	A Award deriv	2022-05-20	2022-05-20	246,639	—	$0	246,639	SEC↗
Marshall Keith W	Chief Financial Officer	A Award deriv	2022-05-20	2022-05-20	86,582	—	$0	86,582	SEC↗
Stenhouse Mark	Chief Operating Officer	A Award deriv	2022-05-20	2022-05-20	86,582	—	$0	86,582	SEC↗
Adams Helen C.	Director	A Award deriv	2022-05-19	2022-05-20	21,526	—	$0	21,526	SEC↗
Hassan Fred	Director	A Award deriv	2022-05-19	2022-05-20	21,013	—	$0	21,013	SEC↗
Hendrix Martin	Director	A Award deriv	2022-05-19	2022-05-20	20,500	—	$0	20,500	SEC↗
Laur James	Director	A Award deriv	2022-05-19	2022-05-20	20,500	—	$0	20,500	SEC↗
PAPA JOSEPH C	Director	A Award deriv	2022-05-19	2022-05-20	22,551	—	$0	22,551	SEC↗
Swain Judith L	Director	A Award deriv	2022-05-19	2022-05-20	20,500	—	$0	20,500	SEC↗
Szela Mary T	Director	A Award deriv	2022-05-19	2022-05-20	20,500	—	$0	20,500	SEC↗
Cedars Sinai Intellectual Prop	10% Owner	J Other	2022-04-05	2022-04-05	142,376	—	$0	4,866,132	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise deriv	2021-12-01	2021-12-03	15,400	—	$0	122,531	SEC↗
McKenna Mark C.	Chairman, President & CEO	M Exercise	2021-12-01	2021-12-03	15,400	$2.90	$44.7K	15,400	SEC↗
McKenna Mark C.	Chairman, President & CEO	A Award deriv	2021-11-14	2021-11-16	290,000	—	$0	290,000	SEC↗
Luo Allison	Chief Medical Officer	A Award deriv	2021-11-14	2021-11-16	113,677	—	$0	113,677	SEC↗
Marshall Keith W	Chief Financial Officer	A Award deriv	2021-11-14	2021-11-16	102,155	—	$0	102,155	SEC↗
Stenhouse Mark	Chief Operating Officer	A Award deriv	2021-11-14	2021-11-16	70,371	—	$0	70,371	SEC↗
Andrews Timothy K.	General Counsel	A Award deriv	2021-11-14	2021-11-16	54,132	—	$0	54,132	SEC↗
PAPA JOSEPH C	Director	A Award deriv	2021-11-14	2021-11-16	2,165	—	$0	2,165	SEC↗
Adams Helen C.	Director	A Award deriv	2021-11-14	2021-11-16	1,083	—	$0	1,083	SEC↗
Hassan Fred	Director	A Award deriv	2021-11-14	2021-11-16	541	—	$0	541	SEC↗
Luo Allison	Chief Medical Officer	A Award deriv	2021-09-08	2021-09-15	4,500	—	$0	4,500	SEC↗
Hassan Fred	Director	A Award deriv	2021-05-14	2021-05-17	40,000	—	$0	40,000	SEC↗
Hendrix Martin	Director	A Award deriv	2021-04-14	2021-04-16	40,000	—	$0	40,000	SEC↗
Laur James	Director	A Award deriv	2021-04-14	2021-04-16	40,000	—	$0	40,000	SEC↗
WONG RODERICK	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	14,462,623	—	$0	0	SEC↗
WONG RODERICK	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	10,177,703	—	$0	0	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	10,177,703	—	$0	0	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	14,462,623	—	$0	0	SEC↗
Yamada Tadataka	Director	C Conversion deriv	2021-03-16	2021-03-16	133,334	—	$0	0	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	1,000,000	—	$0	0	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	12,000,000	—	$0	0	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	3,615,656	—	$0	0	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	25,000,000	—	$0	0	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion deriv	2021-03-16	2021-03-16	2,544,425	—	$0	0	SEC↗
Point72 Biotech Private Invest	Other	C Conversion deriv	2021-03-16	2021-03-17	7,633,277	—	$0	0	SEC↗
Point72 Biotech Private Invest	Other	C Conversion deriv	2021-03-16	2021-03-17	10,846,968	—	$0	0	SEC↗
Cormorant Global Healthcare Ma	Other	C Conversion deriv	2021-03-16	2021-03-18	763,327	—	$0	0	SEC↗
Cormorant Global Healthcare Ma	Other	C Conversion deriv	2021-03-16	2021-03-18	1,084,696	—	$0	0	SEC↗
WONG RODERICK	10% Owner	P Buy	2021-03-16	2021-03-16	800,000	$19.00	$15.20M	800,000	SEC↗
WONG RODERICK	10% Owner	C Conversion	2021-03-16	2021-03-16	1,017,769	—	$0	1,817,769	SEC↗
WONG RODERICK	10% Owner	C Conversion	2021-03-16	2021-03-16	1,446,262	—	$0	3,264,031	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	C Conversion	2021-03-16	2021-03-16	1,446,262	—	$0	2,464,032	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	P Buy	2021-03-16	2021-03-16	850,000	$19.00	$16.15M	3,314,032	SEC↗
PERCEPTIVE ADVISORS LLC	10% Owner	C Conversion	2021-03-16	2021-03-16	1,017,770	—	$0	1,017,770	SEC↗
Adams Helen C.	Director	P Buy	2021-03-16	2021-03-16	500	$19.00	$9.5K	500	SEC↗
PAPA JOSEPH C	Director	P Buy	2021-03-16	2021-03-16	15,000	$19.00	$285.0K	15,000	SEC↗
Stenhouse Mark	Chief Operating Officer	P Buy	2021-03-16	2021-03-16	14,000	$19.00	$266.0K	14,000	SEC↗
Yamada Tadataka	Director	C Conversion	2021-03-16	2021-03-16	13,333	—	$0	13,333	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion	2021-03-16	2021-03-16	100,000	—	$0	692,500	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion	2021-03-16	2021-03-16	254,442	—	$0	4,646,942	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion	2021-03-16	2021-03-16	361,566	—	$0	5,008,508	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion	2021-03-16	2021-03-16	2,500,000	—	$0	4,392,500	SEC↗
CEDARS SINAI MEDICAL CENTER	10% Owner	C Conversion	2021-03-16	2021-03-16	1,200,000	—	$0	1,892,500	SEC↗
Point72 Biotech Private Invest	Other	C Conversion	2021-03-16	2021-03-17	1,084,697	—	$0	1,848,024	SEC↗
Point72 Biotech Private Invest	Other	P Buy	2021-03-16	2021-03-17	800,000	$19.00	$15.20M	2,648,024	SEC↗
Point72 Biotech Private Invest	Other	C Conversion	2021-03-16	2021-03-17	763,327	—	$0	763,327	SEC↗
Cormorant Global Healthcare Ma	Other	C Conversion	2021-03-16	2021-03-18	1,848,022	—	$0	1,848,022	SEC↗
Cormorant Global Healthcare Ma	Other	P Buy	2021-03-16	2021-03-18	375,000	$19.00	$7.13M	2,223,022	SEC↗
Szela Mary T	Director	A Award deriv	2021-03-11	2021-03-11	40,000	—	$0	40,000	SEC↗
Bristol James A	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Bristol James A	Director	D To issuer deriv	2018-02-08	2018-02-12	20,000	—	$0	0	SEC↗
Bristol James A	Director	D To issuer deriv	2018-02-08	2018-02-12	24,000	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	10,000	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	6,666	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	24,000	—	$0	0	SEC↗
Casdin Alexander W.	Director	D To issuer deriv	2018-02-08	2018-02-12	20,000	—	$0	0	SEC↗
Chacko Jacob	Chief Financial Officer	D To issuer deriv	2018-02-08	2018-02-12	25,200	—	$0	0	SEC↗
Chacko Jacob	Chief Financial Officer	D To issuer deriv	2018-02-08	2018-02-12	50,000	—	$0	0	SEC↗
Chacko Jacob	Chief Financial Officer	D To issuer deriv	2018-02-08	2018-02-12	250,000	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	24,000	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	10,000	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	6,666	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	20,000	—	$0	0	SEC↗
Dreismann Heiner	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Freddo James L	Director	D To issuer deriv	2018-02-08	2018-02-12	5,000	—	$0	0	SEC↗
Freddo James L	Director	D To issuer deriv	2018-02-08	2018-02-12	24,000	—	$0	0	SEC↗
Freddo James L	Director	D To issuer deriv	2018-02-08	2018-02-12	6,666	—	$0	0	SEC↗
Freddo James L	Director	D To issuer deriv	2018-02-08	2018-02-12	15,000	—	$0	0	SEC↗
Freddo James L	Director	D To issuer deriv	2018-02-08	2018-02-12	20,000	—	$0	0	SEC↗
Hoerter Steven L.	Director	D To issuer deriv	2018-02-08	2018-02-12	24,000	—	$0	0	SEC↗
Hoerter Steven L.	Director	D To issuer deriv	2018-02-08	2018-02-12	11,666	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	D To issuer deriv	2018-02-08	2018-02-12	48,000	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	D To issuer deriv	2018-02-08	2018-02-12	60,000	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	D To issuer deriv	2018-02-08	2018-02-12	250,000	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	D To issuer deriv	2018-02-08	2018-02-12	40,000	—	$0	0	SEC↗
Kuhlen Christian V	General Counsel and Secretar	D To issuer deriv	2018-02-08	2018-02-12	160,000	—	$0	0	SEC↗
Kuhlen Christian V	General Counsel and Secretar	D To issuer deriv	2018-02-08	2018-02-12	25,000	—	$0	0	SEC↗
Lim Jonathan E	President, CEO & Director	D To issuer deriv	2018-02-08	2018-02-12	100,000	—	$0	0	SEC↗
Lim Jonathan E	President, CEO & Director	D To issuer deriv	2018-02-08	2018-02-12	120,000	—	$0	0	SEC↗
Lim Jonathan E	President, CEO & Director	D To issuer deriv	2018-02-08	2018-02-12	400,000	—	$0	0	SEC↗
McCarthy William R	Chief Business Officer	D To issuer deriv	2018-02-08	2018-02-12	50,000	—	$0	0	SEC↗
McCarthy William R	Chief Business Officer	D To issuer deriv	2018-02-08	2018-02-12	200,000	—	$0	0	SEC↗
Multani Pratik S	Chief Medical Officer	D To issuer deriv	2018-02-08	2018-02-12	50,000	—	$0	0	SEC↗
Multani Pratik S	Chief Medical Officer	D To issuer deriv	2018-02-08	2018-02-12	200,000	—	$0	0	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	D To issuer deriv	2018-02-08	2018-02-12	50,000	—	$0	0	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	D To issuer deriv	2018-02-08	2018-02-12	200,000	—	$0	0	SEC↗
Bristol James A	Director	D To issuer	2018-02-08	2018-02-12	21,845	$27.00	$589.8K	0	SEC↗
Casdin Alexander W.	Director	D To issuer	2018-02-08	2018-02-12	706,464	$27.00	$19.07M	0	SEC↗
Casdin Alexander W.	Director	D To issuer	2018-02-08	2018-02-12	100,000	$27.00	$2.70M	0	SEC↗
Chacko Jacob	Chief Financial Officer	D To issuer	2018-02-08	2018-02-12	70,572	$27.00	$1.91M	0	SEC↗
Freddo James L	Director	D To issuer	2018-02-08	2018-02-12	3,000	$27.00	$81.0K	0	SEC↗
Hornby Zachary	Chief Operating Officer	D To issuer	2018-02-08	2018-02-12	165,748	$27.00	$4.48M	0	SEC↗
Kuhlen Christian V	General Counsel and Secretar	D To issuer	2018-02-08	2018-02-12	22,019	$27.00	$594.5K	0	SEC↗
Lim Jonathan E	President, CEO & Director	D To issuer	2018-02-08	2018-02-12	179,661	$27.00	$4.85M	0	SEC↗
Lim Jonathan E	President, CEO & Director	D To issuer	2018-02-08	2018-02-12	3,350,000	$27.00	$90.45M	0	SEC↗
McCarthy William R	Chief Business Officer	D To issuer	2018-02-08	2018-02-12	22,199	$27.00	$599.4K	0	SEC↗
Multani Pratik S	Chief Medical Officer	D To issuer	2018-02-08	2018-02-12	74,134	$27.00	$2.00M	0	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	D To issuer	2018-02-08	2018-02-12	29,188	$27.00	$788.1K	0	SEC↗
Chacko Jacob	Chief Financial Officer	A Award	2018-01-05	2018-01-05	4,400	—	$0	70,572	SEC↗
Multani Pratik S	Chief Medical Officer	A Award	2018-01-05	2018-01-05	4,400	—	$0	74,134	SEC↗
McCarthy William R	Chief Business Officer	F Tax w/h	2017-12-26	2017-12-28	1,135	$26.70	$30.3K	22,199	SEC↗
Lim Jonathan E	President, CEO and Director	F Tax w/h	2017-12-26	2017-12-28	19,006	$26.70	$507.5K	179,661	SEC↗
Hornby Zachary	Chief Operating Officer	F Tax w/h	2017-12-26	2017-12-28	18,552	$26.70	$495.3K	165,748	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	F Tax w/h	2017-12-26	2017-12-28	2,066	$26.70	$55.2K	29,188	SEC↗
Kuhlen Christian V	General Counsel and Secretar	F Tax w/h	2017-12-26	2017-12-28	1,315	$26.70	$35.1K	22,019	SEC↗
Chacko Jacob	Chief Financial Officer	A Award	2017-12-22	2017-12-22	23,334	—	$0	66,172	SEC↗
Hornby Zachary	Chief Operating Officer	A Award	2017-12-22	2017-12-22	37,167	—	$0	184,300	SEC↗
Kuhlen Christian V	General Counsel and Secretar	A Award	2017-12-22	2017-12-22	23,334	—	$0	23,334	SEC↗
Lim Jonathan E	President, CEO & Director	A Award	2017-12-22	2017-12-22	68,334	—	$0	198,667	SEC↗
Multani Pratik S	Chief Medical Officer	A Award	2017-12-22	2017-12-22	23,334	—	$0	69,734	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	A Award	2017-12-22	2017-12-22	23,334	—	$0	31,254	SEC↗
McCarthy William R	Chief Business Officer	A Award	2017-12-22	2017-12-22	23,334	—	$0	23,334	SEC↗
Lim Jonathan E	President, CEO & Director	A Award	2017-12-22	2017-12-27	68,334	—	$0	198,667	SEC↗
Bristol James A	Director	A Award deriv	2017-06-13	2017-06-19	20,000	—	$0	20,000	SEC↗
Casdin Alexander W.	Director	A Award deriv	2017-06-13	2017-06-19	20,000	—	$0	20,000	SEC↗
Dreismann Heiner	Director	A Award deriv	2017-06-13	2017-06-19	20,000	—	$0	20,000	SEC↗
Freddo James L	Director	A Award deriv	2017-06-13	2017-06-19	20,000	—	$0	20,000	SEC↗
Hoerter Steven L.	Director	A Award deriv	2017-06-13	2017-06-19	11,666	—	$0	11,666	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise deriv	2017-05-03	2017-05-05	2,083	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise deriv	2017-05-03	2017-05-05	10,000	—	$0	40,000	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise deriv	2017-05-03	2017-05-05	1,389	—	$0	0	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise	2017-05-03	2017-05-05	10,000	$1.02	$10.2K	147,133	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise	2017-05-03	2017-05-05	2,083	$0.57	$1.2K	135,744	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise	2017-05-03	2017-05-05	1,389	$0.60	$833	137,133	SEC↗
Lim Jonathan E	President, CEO & Director	M Exercise deriv	2017-02-13	2017-03-10	6,945	—	$0	0	SEC↗
Lim Jonathan E	President, CEO & Director	M Exercise	2017-02-13	2017-03-10	6,945	$0.60	$4.2K	130,333	SEC↗
Bristol James A	Director	J Other	2017-01-05	2018-01-09	178	—	$0	21,845	SEC↗
Chacko Jacob	Chief Financial Officer	A Award deriv	2017-01-05	2017-01-06	50,000	—	$0	50,000	SEC↗
Hornby Zachary	Chief Operating Officer	A Award deriv	2017-01-05	2017-01-06	60,000	—	$0	60,000	SEC↗
Kuhlen Christian V	General Counsel and Secretar	A Award deriv	2017-01-05	2017-01-06	25,000	—	$0	25,000	SEC↗
Lim Jonathan E	President, CEO & Director	A Award deriv	2017-01-05	2017-01-06	120,000	—	$0	120,000	SEC↗
McCarthy William R	Chief Business Officer	A Award deriv	2017-01-05	2017-01-06	50,000	—	$0	50,000	SEC↗
Multani Pratik S	Chief Medical Officer	A Award deriv	2017-01-05	2017-01-06	50,000	—	$0	50,000	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	A Award deriv	2017-01-05	2017-01-06	50,000	—	$0	50,000	SEC↗
Hoerter Steven L.	Director	A Award deriv	2016-12-08	2016-12-09	24,000	—	$0	24,000	SEC↗
Bristol James A	Director	P Buy	2016-08-15	2016-08-16	5,000	$5.65	$28.3K	21,667	SEC↗
Kuhlen Christian V	General Counsel and Secretar	A Award deriv	2016-07-05	2016-07-06	160,000	—	$0	160,000	SEC↗
Casdin Alexander W.	Director	A Award deriv	2016-06-13	2016-06-15	15,000	—	$0	15,000	SEC↗
Dreismann Heiner	Director	A Award deriv	2016-06-13	2016-06-15	15,000	—	$0	15,000	SEC↗
Bristol James A	Director	A Award deriv	2016-06-13	2016-06-15	15,000	—	$0	15,000	SEC↗
Freddo James L	Director	A Award deriv	2016-06-13	2016-06-15	15,000	—	$0	15,000	SEC↗
Casdin Alexander W.	Director	P Buy	2016-05-04	2016-05-04	232,000	$6.25	$1.45M	706,464	SEC↗
Lim Jonathan E	President, CEO & Director	M Exercise deriv	2016-04-11	2016-04-13	26,388	—	$0	6,945	SEC↗
Lim Jonathan E	President, CEO & Director	M Exercise	2016-04-11	2016-04-13	26,388	$0.60	$15.8K	123,388	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise deriv	2016-03-17	2016-04-13	17,917	—	$0	2,083	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise deriv	2016-03-17	2016-04-13	5,277	—	$0	1,389	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise	2016-03-17	2016-04-13	5,277	$0.60	$3.2K	133,661	SEC↗
Hornby Zachary	Chief Operating Officer	M Exercise	2016-03-17	2016-04-13	17,917	$0.57	$10.2K	128,384	SEC↗
Chacko Jacob	Chief Financial Officer	P Buy	2016-03-17	2016-03-21	10,000	$5.64	$56.4K	42,838	SEC↗
Freddo James L	Director	P Buy	2016-03-17	2016-03-21	3,000	$5.39	$16.2K	3,000	SEC↗
Lim Jonathan E	President, CEO & Director	P Buy	2016-03-17	2016-03-21	24,852	$5.51	$136.9K	3,350,000	SEC↗
City Hill Venture Partners I,	10% Owner	P Buy	2016-03-17	2016-03-21	24,852	$5.51	$136.9K	3,350,000	SEC↗
Dreismann Heiner	Director	A Award deriv	2016-03-10	2016-03-11	15,000	—	$0	15,000	SEC↗
Casdin Alexander W.	Director	A Award deriv	2016-03-10	2016-03-11	15,000	—	$0	15,000	SEC↗
Lim Jonathan E	President, CEO & Director	A Award	2016-01-07	2016-01-11	72,000	—	$0	97,000	SEC↗
Hornby Zachary	Chief Operating Officer	A Award	2016-01-07	2016-01-11	28,800	—	$0	110,467	SEC↗
Chacko Jacob	Chief Financial Officer	A Award	2016-01-07	2016-01-11	26,400	—	$0	32,838	SEC↗
Onaitis Matthew	General Counsel and Secretar	A Award	2016-01-07	2016-01-11	26,400	—	$0	46,400	SEC↗
WILD ROBERT	Sr. VP, Research and CSO	A Award	2016-01-07	2016-01-11	12,000	—	$0	13,200	SEC↗
Multani Pratik S	Chief Medical Officer	A Award	2016-01-07	2016-01-11	26,400	—	$0	46,400	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	A Award	2016-01-07	2016-01-11	7,920	—	$0	7,920	SEC↗
BILINSKY IGOR	GM, Immuno-Oncology/SVP Sp O	A Award	2016-01-07	2016-01-11	6,960	—	$0	6,960	SEC↗
Chacko Jacob	Chief Financial Officer	P Buy	2015-12-16	2015-12-17	1,500	$12.00	$18.0K	6,438	SEC↗
McCarthy William R	Chief Business Officer	A Award deriv	2015-12-07	2015-12-07	200,000	—	$0	200,000	SEC↗
BILINSKY IGOR	GM, Immuno-Oncology/SVP Sp O	A Award deriv	2015-09-17	2015-09-17	200,000	—	$0	200,000	SEC↗
Start Valerie Denise Harding	SVP, Chemistry, Mfg & Contro	A Award deriv	2015-09-02	2015-09-02	200,000	—	$0	200,000	SEC↗
City Hill Venture Partners I,	10% Owner	P Buy	2015-08-20	2015-08-21	40	$12.77	$511	3,325,148	SEC↗
City Hill Venture Partners I,	10% Owner	P Buy	2015-08-20	2015-08-21	1,700	$12.69	$21.6K	3,325,108	SEC↗
Lim Jonathan E	President, CEO & Director	P Buy	2015-08-20	2015-08-21	1,700	$12.69	$21.6K	3,325,108	SEC↗
Lim Jonathan E	President, CEO & Director	P Buy	2015-08-20	2015-08-21	40	$12.77	$511	3,325,148	SEC↗
Chacko Jacob	Chief Financial Officer	A Award	2015-08-20	2015-08-21	1,500	$12.40	$18.6K	4,938	SEC↗
Chacko Jacob	Chief Financial Officer	P Buy	2015-08-20	2015-08-27	1,500	$12.40	$18.6K	4,938	SEC↗
City Hill Venture Partners I,	10% Owner	P Buy	2015-08-19	2015-08-21	6,500	$12.95	$84.2K	3,323,168	SEC↗
City Hill Venture Partners I,	10% Owner	P Buy	2015-08-19	2015-08-21	240	$13.05	$3.1K	3,323,408	SEC↗
Lim Jonathan E	President, CEO & Director	P Buy	2015-08-19	2015-08-21	6,500	$12.95	$84.2K	3,323,168	SEC↗
Lim Jonathan E	President, CEO & Director	P Buy	2015-08-19	2015-08-21	240	$13.05	$3.1K	3,323,408	SEC↗
Parker Bernard	Chief Commercial Officer	A Award deriv	2015-07-22	2015-07-22	200,000	—	$0	200,000	SEC↗